Hideki Matsubara

Head of China Alinamin Unit at Takeda Pharmaceuticals (formerly Nycomed) - Lexington, MA, US

Hideki Matsubara's Colleagues at Takeda Pharmaceuticals (formerly Nycomed)
Nori Takeda

Head of Global Consolidaiton & Japan Reporting

Contact Nori Takeda

Tomoyuki Otsuka

Vice President, Head, Global Public Affairs

Contact Tomoyuki Otsuka

Takeru Kusumoto

Director, Japan Project Lead, Therapeutic Area Strategic Unit

Contact Takeru Kusumoto

Masayuki Yokoyama

Attending Veterinarian, Associate Director, Site Engineering & Operations

Contact Masayuki Yokoyama

View All Hideki Matsubara's Colleagues
Hideki Matsubara's Contact Details
HQ
224-554-6500
Location
Company
Takeda Pharmaceuticals (formerly Nycomed)
Hideki Matsubara's Company Details
Takeda Pharmaceuticals (formerly Nycomed) logo, Takeda Pharmaceuticals (formerly Nycomed) contact details

Takeda Pharmaceuticals (formerly Nycomed)

Lexington, MA, US • >10000 Employees
Major Drugs

On October 1, 2011, Takeda Pharmaceutical Company Limited acquired Nycomed. Through the acquisition, Takeda, the largest pharma company in Asia, broadened its coverage of the global pharmaceutical market, especialy in Europe and emergig markets. More information on http://www.takeda.com. The below information is from before the acquisition: Nycomed is a privately owned global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Its R&D is structured around collaborations. In-licensing and expanding in emerging markets are cornerstones of the company's growth strategy. Nycomed employs 12,500 associates worldwide, and its products are sold in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, Latin America, Asia and the Middle East. In the US and Japan its products are available through best in class partners. Headquartered in Zurich, Switzerland, the company generated total sales of € 3.2 billion in 2010 and an adjusted EBITDA of € 851 million.

Branded Pharmaceuticals Gastroenterology Respiratory Conditions Inflammatory Diseases Pain Management Osteoporosis Treatment Over The Counter
Details about Takeda Pharmaceuticals (formerly Nycomed)
Frequently Asked Questions about Hideki Matsubara
Hideki Matsubara currently works for Takeda Pharmaceuticals (formerly Nycomed).
Hideki Matsubara's role at Takeda Pharmaceuticals (formerly Nycomed) is Head of China Alinamin Unit.
Hideki Matsubara's email address is ***@takeda.com. To view Hideki Matsubara's full email address, please signup to ConnectPlex.
Hideki Matsubara works in the Major Drugs industry.
Hideki Matsubara's colleagues at Takeda Pharmaceuticals (formerly Nycomed) are Nori Takeda, Tomoyuki Otsuka, Katsuhito Murase, Mika Murabayashi, Takeru Kusumoto, Ikuhiko Wada, Masayuki Yokoyama and others.
Hideki Matsubara's phone number is 224-554-6500
See more information about Hideki Matsubara